Detalhe da pesquisa
1.
Automated Quantitative CD8+ Tumor-Infiltrating Lymphocytes and Tumor Mutation Burden as Independent Biomarkers in Melanoma Patients Receiving Front-Line Anti-PD-1 Immunotherapy.
Oncologist
; 2024 Apr 24.
Artigo
Inglês
| MEDLINE | ID: mdl-38655867
2.
An updated analysis of 4 randomized ECOG trials of high-dose interferon in the adjuvant treatment of melanoma.
Cancer
; 125(17): 3013-3024, 2019 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31067358
3.
Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumab.
J Transl Med
; 15(1): 39, 2017 02 21.
Artigo
Inglês
| MEDLINE | ID: mdl-28222797
4.
A retrospective analysis of the impact of the COVID-19 pandemic on staging at presentation of patients with invasive melanoma.
J Am Acad Dermatol
; 87(4): 906-908, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35551967
5.
B7-DC-Ig enhances vaccine effect by a novel mechanism dependent on PD-1 expression level on T cell subsets.
J Immunol
; 189(5): 2338-47, 2012 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-22837483
6.
Matched three-dimensional organoids and two-dimensional cell lines of melanoma brain metastases mirror response to targeted molecular therapy.
bioRxiv
; 2024 Jan 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38328251
7.
Radiomic analysis of patient and inter-organ heterogeneity in response to immunotherapies and BRAF targeted therapy in metastatic melanoma.
medRxiv
; 2024 Apr 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38712112
8.
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations.
Nat Rev Immunol
; 2023 Dec 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38057451
9.
Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study.
Front Oncol
; 13: 1075823, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37397389
10.
Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy.
Front Immunol
; 14: 1187332, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37388743
11.
Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
J Immunother Cancer
; 11(10)2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37857525
12.
Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
bioRxiv
; 2023 Aug 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37662409
13.
Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum are prognostic of melanoma patient outcomes.
Front Immunol
; 14: 1171978, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37435077
14.
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study.
EClinicalMedicine
; 65: 102290, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37965433
15.
Anti-PD-1 synergizes with cyclophosphamide to induce potent anti-tumor vaccine effects through novel mechanisms.
Eur J Immunol
; 41(10): 2977-86, 2011 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-21710477
16.
Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma.
Front Oncol
; 12: 1022496, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36505793
17.
Search for effective treatments in patients with advanced refractory melanoma continues: can novel intratumoral therapies deliver?
J Immunother Cancer
; 9(7)2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34312244
18.
Immune-Related Adverse Events in PD-1 Treated Melanoma and Impact Upon Anti-Tumor Efficacy: A Real World Analysis.
Front Oncol
; 11: 749064, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34900695
19.
Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma.
Clin Cancer Res
; 27(15): 4195-4204, 2021 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33753453
20.
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients.
Science
; 371(6529): 595-602, 2021 02 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33542131